Top Story
Malaria vaccine proves promising in Mali trial
An experimental malaria vaccine originally developed by GlaxoSmithKline and the U.S. Army has produced dramatic results in an early-stage trial in Mali. Researchers recruited 100 children who are between 1 and 6 years old for the trial and found that the jab provided the same kind of immunity as lifelong exposure to the disease. The children's immune response jumped 100-fold. ReportNews Timeline
Breaking swine flu news
Want more information on the ongoing swine flu outbreak? Get breaking news and more details here. TimelineFrom The Network
Also Noted
H1N1
> Sales of the H1N1 vaccine helped lift GlaxoSmithKline's profit to $2.6 billion in the fourth quarter. Report
> The Czech Republic says it is in talks with GlaxoSmithKline to see if it can cancel at least part of its scheduled shipment of H1N1 vaccine. Story
> A total of 112 people have been killed by swine flu in Hungary. Story
Vaccine Research
> Bill Gates has pledged to give $10 billion of his fortune to research, develop and deliver new vaccines that can prevent diarrhea and pneumonia. "We must make this the decade of vaccines," Gates said during the World Economic Forum in Davos, Switzerland. Report
Read more >>Press Releases
- Sistemic Closes $1m Series A Funding Round
- Lux Biosciences Files for LUVENIQ Approval in US and Europe for Noninfectious Uveitis
- Virus-Like Particle Vaccine Protects Monkeys from Chikungunya Virus
- GSK launches new specialist unit to research and develop medicines for rare diseases
- Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
- Leading Chinese Pharmaceuticals Retailer and Distributor Lerentang Group Selects Manhattan Associates




